ABF has today announced the acquisition of Novartis AG's Food and Beverage business for €272.5 million (£171 million). This comprises Ovaltine and associated brands. Ovaltine, or Ovomaltine outside the UK, is a large, growing international brand with leading market positions in Europe and Asia.